Persistent Asset Partners’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-184
Closed -$2.76K – 411
2025
Q4
$2.76K Buy
+184
New +$5.27K ﹤0.01% 342

Other funds holding LEGN

Persistent Asset Partners's LEGN Position: Q3 2026 in Review

Persistent Asset Partners sold out of Legend Biotech (LEGN) in Q3 2026, closing a stake of 9,579 shares — an estimated $277K sold.

Persistent Asset Partners first reported a position in LEGN in Q2 2026 and held it in 1 quarter. The position peaked at $277K in Q2 2026. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Persistent Asset Partners reported no remaining Legend Biotech position as of Q3 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 9,579 Legend Biotech shares in Q3 2026, an estimated $277K.
  • Persistent Asset Partners first reported a position in Legend Biotech in Q2 2026 and held it in 1 quarter.
  • Persistent Asset Partners's Legend Biotech position peaked at $277K in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.